{ "data": { "asOf": "2026-10-30T22:27:51.777Z", "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "byRegistry": { "clinicaltrials_gov": 1 }, "canonicalTrial": { "canonicalId": "NCT06467344", "title": "Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)", "scientificTitle": "ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy", "status": "recruiting", "studyType": "interventional", "phase": [ "PHASE1", "PHASE2" ], "conditions": [ "Stargardt Disease", "Cone Rod Dystrophy", "Juvenile Macular Degeneration", "Stargardt Disease 1" ], "interventions": [ { "name": "ACDN-01", "type": "DRUG", "description": "ACDN-01 is an AAV-based vector carrying a DNA construct encoding for an ABCA4 RNA exon editor. One time administration is via subretinal injection." } ], "sponsor": { "name": "Ascidian Therapeutics, Inc", "type": "INDUSTRY" }, "locations": [ { "city": "San Francisco", "country": "United States", "facility": "University of San Francisco" }, { "city": "Gainesville", "country": "United States", "facility": "Vitreo Retinal Associates" }, { "city": "Miami", "country": "United States", "facility": "Bascom Palmer Eye Institute" }, { "city": "Baltimore", "country": "United States", "facility": "Wilmer Eye Institute at John Hopkins" }, { "city": "Boston", "country": "United States", "facility": "Massachusetts Eye and Ear" }, { "city": "Ann Arbor", "country": "United States", "facility": "University of Michigan Kellogg Eye Center" }, { "city": "Cincinnati", "country": "United States", "facility": "Cincinnati Eye Institute" }, { "city": "Portland", "country": "United States", "facility": "Casey Eye Institute OHSU" }, { "city": "Philadelphia", "country": "United States", "facility": "Children's Hospital of Philadelphia" }, { "city": "Dallas", "country": "United States", "facility": "Retina Foundation of the Southwest" }, { "city": "Houston", "country": "United States", "facility": "Retina Consultants of Texas" } ], "outcomes": { "other": [ "To assess for evidence of preliminary efficacy of ACDN-01 based on best corrected visual acuity.", "To assess for evidence of preliminary efficacy of ACDN-01 based on patient reported outcome measures.", "To assess for evidence of preliminary efficacy of ACDN-01 based on contrast sensitivity.", "To assess for evidence of preliminary efficacy of ACDN-01 based on contrast sensitivity.", "To assess for evidence of preliminary efficacy of ACDN-01 based on microperimetry.", "To assess for evidence of preliminary efficacy of ACDN-01 based on microperimetry.", "To assess for evidence of preliminary efficacy of ACDN-01 based on microperimetry." ], "primary": [ "Safety and tolerability of ACDN-01 as measured by the number and severity of adverse events and serious adverse events." ], "secondary": [ "Maximum tolerated dose for subsequent clinical evaluation will be determined by review of all available safety and tolerability data.", "To evaluate for evidence of preliminary efficacy based on fundus autofluorescence (FAF).", "To evaluate for evidence of preliminary efficacy based on optical coherence tomography (OCT)." ] }, "eligibility": { "sex": "ALL", "criteria": "Key Inclusion Criteria:\n\n* Presence of mutations in the ABCA4 gene\n* ABCA4 retinopathy phenotype (Stargardt disease type 1 or cone-rod dystrophy)\n* Area of atrophy located in the macula of the study eye\n* BCVA of 20/50 (0.4 logMAR) or worse\n\nKey Exclusion Criteria:\n\n* The presence of pathogenic or likely pathogenic mutations in other genes known to cause cone-rod dystrophy or Stargardt maculopathy\n* Retinal disease other than ABCA4-related retinopathy\n* Presence of a medical condition (systemic or ophthalmic), psychiatric condition, including substance abuse disorder, or physical examination or laboratory finding that may in the opinion of the principal investigator and sponsor preclude adherence to the scheduled study visits, safe participation in the study, or affect the results of the study.", "minimumAge": "12 Years", "healthyVolunteers": false }, "enrollment": { "type": "ESTIMATED", "count": 15 }, "startDate": "2024-06-11", "completionDate": "2030-12-01", "lastUpdated": "2026-10-07T00:00:00.000Z", "firstPosted": "2024-06-21T00:00:00.000Z", "resultsAvailable": false, "sourceRegistries": [ "clinicaltrials_gov" ], "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06467344" ] }, "identifiers": [ { "idType": "nct", "idValue": "NCT06467344", "declaredBy": "clinicaltrials_gov" } ], "sourceRecords": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT06467344", "sourceUrl": "https://clinicaltrials.gov/study/NCT06467344", "sourceStatus": "RECRUITING", "retrievedAt": "2026-10-28T04:32:32.826Z", "payloadSha256": "bcaf3c960660e3a11073d002ca7fd3deebc494cc5627e9664918ecf443642a12", "piiRedacted": true } ], "citation": { "canonicalId": "NCT06467344", "sources": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT06467344", "verifyAt": "https://clinicaltrials.gov/study/NCT06467344", "retrievedAt": "2026-10-28T04:32:32.826Z", "payloadSha256": "bcaf3c960660e3a11073d002ca7fd3deebc494cc5627e9664918ecf443642a12", "text": "ClinicalTrials.gov, record NCT06467344 (https://clinicaltrials.gov/study/NCT06467344), retrieved 2026-10-28, licence: public-domain." } ], "crossRegistry": false, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "text": "Trial NCT06467344, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.", "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there." }, "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served." }, "_meta": { "api": "The Last Economy Wire: World Trials API", "version": "1.0", "schemaVersion": "1", "correlationId": "req_bJ3yx2GOTNm_", "generatedAt": "2026-10-30T22:27:51.777Z", "documentation": "https://negativeresistance.com/embed", "license": "Free for any use. Attribution appreciated.", "degraded": false, "provenance": { "sources": [ "clinicaltrials_gov" ], "attribution": { "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs" }, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "limitations": [], "provenanceEndpoint": "/api/v1/sources" }, "freshness": { "newestEvidenceAt": null, "lastSyncedAt": { "clinicaltrials_gov": "2026-10-28T04:33:30.663Z" }, "degradedSources": [], "worldwide": false, "maxAgeHours": 65.9, "fromCache": false }, "links": { "discovery": "https://negativeresistance.com/api/v1", "openapi": "https://negativeresistance.com/api/v1/openapi.json", "mcp": "https://negativeresistance.com/api/v1/mcp", "agentCard": "https://negativeresistance.com/.well-known/agent.json", "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json", "sdk": "https://negativeresistance.com/api/v1/sdk", "status": "https://negativeresistance.com/api/v1/status", "provenance": "https://negativeresistance.com/api/v1/sources", "contract": "https://negativeresistance.com/api/v1/contract", "curriculum": "https://negativeresistance.com/api/v1/curriculum", "graph": "https://negativeresistance.com/api/v1/graph", "openQuestions": "https://negativeresistance.com/api/v1/open-questions", "scoreboard": "https://negativeresistance.com/api/v1/scoreboard", "findings": "https://negativeresistance.com/api/v1/findings", "claims": "https://negativeresistance.com/api/v1/claims", "threads": "https://negativeresistance.com/api/v1/threads", "assignment": "https://negativeresistance.com/api/v1/assignment", "changes": "https://negativeresistance.com/api/v1/changes", "hello": "https://negativeresistance.com/api/v1/hello", "errors": "https://negativeresistance.com/api/v1/errors", "webhooks": "https://negativeresistance.com/api/v1/webhooks", "a2a": "https://negativeresistance.com/api/v1/a2a", "deadEnds": "https://negativeresistance.com/api/v1/dead-ends", "decompositions": "https://negativeresistance.com/api/v1/decompositions", "rungs": "https://negativeresistance.com/api/v1/rungs", "methods": "https://negativeresistance.com/api/v1/methods", "reality": "https://negativeresistance.com/api/v1/reality", "council": "https://negativeresistance.com/api/v1/council", "calibration": "https://negativeresistance.com/api/v1/calibration", "freshness": "https://negativeresistance.com/api/v1/freshness", "mission": "https://negativeresistance.com/api/v1/mission", "twin": "https://negativeresistance.com/api/v1/twin", "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment", "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell", "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model", "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json", "collaborate": "https://negativeresistance.com/collaborate", "manifesto": "https://negativeresistance.com/about", "documentation": "https://negativeresistance.com/embed", "connect": "https://negativeresistance.com/connect", "llmsTxt": "https://negativeresistance.com/llms.txt", "llmsFullTxt": "https://negativeresistance.com/llms-full.txt" }, "disclaimer": "Research data from public registries and literature; not medical advice." } }